Bookvolume editors, Holger Christiansen, Nina Merete Christiansen.
Contents:
Clinical features of progressive neuroblastoma / Simon, T.
DNA copy number changes and beyond / Fieuw, A.; Schulte, J.; De Preter, K.; Speleman, F.
Genomic alterations and abnormal cell cycle in high-risk neuroblastoma / Capasso, M.; Sidarovich, V.; Quattrone, A.; Tonini, G.P.
MYCN and microRNAs / Althoff, K.; Schulte, J.H.
MYCN and its posttranslational regulation in neuroblastoma / Otto, T.
Neuroblastoma and the P53 pathway / Chen, L.; Tweddle, D.A.
Targeting cell death pathways in neuroblastoma / Fulda, S.
Neuroblastoma and angiogenesis / Russler, J.
The role of the anaplastic lymphoma kinase receptor in neuroblastoma / Yeung, C.M.; George, R.E.
Molecular-targeted therapy in refractory or relapsed neuroblastoma / Corbacioglu, S.
Immune regulation in neuroblastoma / Fest, S.; Starke, S.
Approaches to passive and active vaccination against neuroblastoma / Lode, H.N.
Role of cell therapy in neuroblastoma / Bremm, M.; Brehm, C.; Huenecke, S.; Rettinger, E.; Bader, P.
Minimal residual disease in neuroblastoma / Weber, A.